AstraZeneca Files Legal Challenge to Some Drug-Price Provisions of IRA
By Will Feuer AstraZeneca said it has filed a legal challenge to certain aspects of the drug price negotiation provisions of the Inflation Reduction Act,...
Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer AstraZeneca said it has filed a legal challenge to certain aspects of the drug price negotiation provisions of the Inflation Reduction Act,...
AstraZeneca PLC on Thursday said both its Soliris and Lynparza treatments have been approved in Japan. The Cambridge-based pharmaceutical company said Soliris received approval for the treatment of...
AstraZeneca PLC and Merck & Co Inc on Thursday jointly said its Lynparza treatments have been approved in Japan. Merck & Co is a New Jersey, US-headquartered pharmaceutical maker. AstraZeneca is a...
The Japanese Ministry of Health, Labour, and Welfare has approved the combination of olaparib plus abiraterone acetate and prednisone or prednisolone for the treatment of adult patients with BRCA-mutated castration-resistant prostate cancer with distant metastasis.
Enhertu is a HER2-directed ADC.